Who Exports Ephedrine from India — 59 Suppliers Behind a $22.5M Market
India's ephedrine export market is supplied by 59 active exporters who collectively shipped $22.5M across 389 shipments. MANKIND PHARMA LIMITED leads with a 20.2% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LIMITED and LABORATE PHARMACEUTICALS INDIA LTD. The top 5 suppliers together control 67.8% of total export value, reflecting a concentrated market structure.
Top Ephedrine Exporters from India — Ranked by Export Value
MANKIND PHARMA LIMITED is the leading ephedrine exporter from India, holding a 20.2% share of the $22.5M market across 389 shipments from 59 exporters. The top 5 suppliers — MANKIND PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, LABORATE PHARMACEUTICALS INDIA LTD, GRANULES INDIA LIMITED, DR REDDYS LABORATORIES LIMITED — collectively control 67.8% of total export value, indicating a moderately concentrated market. Individual shares are: MANKIND PHARMA LIMITED (20.2%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (14.8%), LABORATE PHARMACEUTICALS INDIA LTD (14.4%), GRANULES INDIA LIMITED (9.4%), DR REDDYS LABORATORIES LIMITED (9.1%).
Top Ephedrine Exporters from India
Ranked by export value · 59 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $4.6M | 1 | 20.2% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $3.3M | 4 | 14.8% |
| 3 | LABORATE PHARMACEUTICALS INDIA LTD 1-980 KOLD TIME TABLET | $3.2M | 1 | 14.4% |
| 4 | GRANULES INDIA LIMITED IBUPROFEN 200MG AND PSEUDOEPHEDRINE HCLIBUPROFEN 200MG AND PSEUDOEPHEDRINE HCL30MG TABLETS | $2.1M | 1 | 9.4% |
| 5 | DR REDDYS LABORATORIES LIMITED EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $2.0M | 1 | 9.1% |
| 6 | LABORATE PHARMACEUTICAL INDIA LIMITED 1-980 KOLD TIME TABLET | $1.2M | 1 | 5.1% |
| 7 | CAPLIN STERILES LIMITED EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $1.1M | 1 | 4.7% |
| 8 | GLAND PHARMA LTD EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $745.2K | 1 | 3.3% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LTD EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $402.0K | 1 | 1.8% |
| 10 | VENOR PHARMA LIMITED CETRIZET D TABLETS NOSFEXOFENADINE &PSEUDOEPHEDRINE HYDROCHLORBRAND.EPHEVER INJ. EPHEDRINE HCL BP 30MG | $395.9K | 17 | 1.8% |
| 11 | GLOBAL PHARMATECH PRIVATE LIMITED EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $357.3K | 1 | 1.6% |
| 12 | MAIVA PHARMA PRIVATE LIMITED EPHEDRINE SULFATEINJ USP 50MG/ML 25S USEPHEDRINE SULFATE INJECTION USP 50MG/ML- 1MLEPHEDRINE SULFATE INJECTION,USP | $352.5K | 1 | 1.6% |
| 13 | SWISS PARENTERALS LIMITED EPHEDRINE INJECTION BP 30 MG/ML,1MLEPHEDRINE INJECTION BP 30 MG/ML,1 ML (31EPHEDRINE INJECTION BP 30 MG/ML, 1 ML 3 | $348.5K | 8 | 1.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ephedrine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MANKIND PHARMA LIMITED | Approved | Yes | Yes | Not verified | Holds USFDA, WHO GMP, and EU GMP certifications. |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | Warning Letter (October 2 | Yes | Yes | Not verified | Received FDA warning letter for Halol facility; holds WHO GMP and EU GMP certifi |
| GRANULES INDIA LIMITED | Approved | Yes | Yes | Not verified | Holds USFDA, WHO GMP, and EU GMP certifications. |
| GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED | Warning Letter (October 2 | Yes | Yes | Not verified | Received FDA warning letter; holds WHO GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 4 leading Ephedrine exporters from India. 2 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 4 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ephedrine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as India's "Bulk Drug Capital," is a pivotal center for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, underscores Hyderabad's emphasis on research and development in pharmaceuticals. This robust infrastructure positions Hyderabad as a significant contributor to the production of APIs, including ephedrine.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with a strong presence of companies like Zydus Cadila and Torrent Pharmaceuticals. The region's well-established infrastructure and regulatory compliance make it a hub for the production of finished dosage forms. While the primary focus is on formulations, the presence of comprehensive manufacturing facilities suggests potential involvement in the production of compounds like ephedrine.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for India's pharmaceutical industry. This region houses the headquarters of industry giants such as Sun Pharmaceutical Industries Limited and Cipla. With approximately 25-30% of India's total pharmaceutical output and over 40% of the nation's pharmaceutical R&D centers, Maharashtra plays a pivotal role in both manufacturing and exporting pharmaceutical products, including ephedrine.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, largely due to favorable tax incentives and industrial policies. The region hosts over 1,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Cipla. Baddi's strategic location and supportive infrastructure have made it a preferred destination for pharmaceutical manufacturing, potentially including the production of ephedrine.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supply chain disruptions, consider sourcing ephedrine from multiple suppliers across different pharmaceutical clusters, including Hyderabad, Ahmedabad-Vadodara, Mumbai-Thane-Raigad, and Baddi-Nalagarh.
- Assess Supplier Capabilities: Evaluate potential suppliers based on their manufacturing capabilities, regulatory compliance, and track record in producing APIs like ephedrine.
- Monitor Regulatory Developments: Stay informed about regulatory changes and compliance requirements in key pharmaceutical clusters to ensure uninterrupted supply and adherence to quality standards.
- Leverage Export Hubs: Utilize the export infrastructure of regions like Mumbai-Thane-Raigad to facilitate efficient distribution of ephedrine to international markets.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ephedrine exporters from India
MANKIND PHARMA LIMITED — Mankind Pharma acquires BSV for INR 13,768 Crores
Mankind Pharma completed the acquisition of 100% stake in Bharat Serums and Vaccines Limited, enhancing its portfolio in women's health and critical care segments. IMPACT: This strategic acquisition is expected to bolster Mankind Pharma's manufacturing capabilities, potentially increasing its Ephedrine production and export capacity.
Impact: This strategic acquisition is expected to bolster Mankind Pharma's manufacturing capabilities, potentially increasing its Ephedrine production and export capacity.
MANKIND PHARMA LIMITED — Mankind Pharma secures rights to develop Actimed's products in South Asia
Mankind Pharma entered into a licensing agreement with Actimed Therapeutics, granting it exclusive rights to develop and commercialize Actimed's products for cachexia treatment in India and South Asian territories. IMPACT: While this collaboration focuses on cachexia treatments, it may lead to expanded R&D capabilities that could indirectly benefit Ephedrine-related product development.
Impact: While this collaboration focuses on cachexia treatments, it may lead to expanded R&D capabilities that could indirectly benefit Ephedrine-related product development.
DR REDDYS LABORATORIES LIMITED — Dr. Reddy's acquires Mayne Pharma's U.S. generics portfolio
Dr. Reddy's Laboratories announced an agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio, including approximately 45 commercial products and additional pipeline products. IMPACT: This acquisition enhances Dr. Reddy's presence in the U.S. market, potentially increasing demand for Ephedrine exports to support the expanded product portfolio.
Impact: This acquisition enhances Dr. Reddy's presence in the U.S. market, potentially increasing demand for Ephedrine exports to support the expanded product portfolio.
Common Questions — Ephedrine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ephedrine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MANKIND PHARMA LIMITED leads with 27 recorded shipments worth $4.6M. SUN PHARMACEUTICAL INDUSTRIES LIMITED (45 shipments) and LABORATE PHARMACEUTICALS INDIA LTD (35 shipments) are also established high-volume exporters.
Q How many ephedrine manufacturers are there in India?
India has 59 active ephedrine exporters with a combined export market of $22.5M across 389 shipments to 56 countries. The top 5 suppliers hold 67.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ephedrine from India?
Average FOB unit price: $11.28 per unit, ranging from $0.01 to $135.06. Average shipment value: $57.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 59 verified Indian exporters of Ephedrine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 389 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 56 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
389 Verified Shipments
59 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists